- Report
- October 2024
- 188 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- November 2024
- 150 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- January 2025
- 185 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- April 2023
- 120 Pages
Global
From €4516EUR$4,750USD£3,794GBP
Johne's disease, also known as paratuberculosis, is a chronic infectious disease that affects the intestinal tract of ruminant animals, such as cattle, sheep, goats, and deer. Caused by the bacterium ''Mycobacterium avium'' subsp. ''paratuberculosis'' (MAP), the disease results in weight loss, diarrhea, decreased milk production, and eventually death. The diagnosis of Johne's disease is complex due to the slow progression of the infection and the difficulty of detecting the organism in the early stages.
The market for Johne's disease diagnostics within animal healthcare encompasses a range of tests and services aimed at identifying and managing the condition in livestock populations. Diagnostic methods include serological tests such as ELISA (enzyme-linked immunosorbent assay), which detects antibodies against MAP, and fecal culture or PCR (polymerase chain reaction) tests to identify the presence of the bacterium itself. The development of accurate and rapid diagnostic tools is crucial for early detection, which enables better management and control of the disease through biosecurity measures, vaccination, and targeted culling of infected animals.
Several companies participate in the Johne's disease diagnostics market, offering various testing solutions and tools for veterinarians and livestock producers. Notable firms in this sector include IDEXX Laboratories, Thermo Fisher Scientific, Zoetis, Prionics, Bio-Rad Laboratories, and Merck Animal Health. These companies provide a range of diagnostic products and Show Less Read more